Literature DB >> 14670330

Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

Gustavo H Dayan1, Lisa Cairns, Nalinee Sangrujee, Anne Mtonga, Van Nguyen, Peter Strebel.   

Abstract

The vaccination program in Zambia includes one dose of measles vaccine at 9 months of age. The objective of this study was to compare the cost-effectiveness of the current one-dose measles vaccination program with an immunization schedule in which a second dose is provided either through routine health services or through supplemental immunization activities (SIAs). We simulated the expected cost and impact of the vaccination strategies for an annual cohort of 400,000 children, assuming 80% vaccination coverage in both routine and SIAs and an analytic horizon of 15 years. A vaccination program which includes SIAs reaching children not previously vaccinated would prevent on additional 29,242 measles cases and 1462 deaths for each vaccinated birth cohort when compared with a one-dose program. Given the parameters established for this analysis, such a program would be cost-saving and the most cost-effective vaccination strategy for Zambia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670330     DOI: 10.1016/j.vaccine.2003.07.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.

Authors:  Timothy J Tucker; Gatsha Mazithulela
Journal:  BMJ       Date:  2004-08-21

2.  The cost-effectiveness of rotavirus vaccination in Malawi.

Authors:  Stephen A Berry; Benjamin Johns; Chuck Shih; Andrea A Berry; Damian G Walker
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

3.  Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Authors:  Lara J Wolfson; François Gasse; Shook-Pui Lee-Martin; Patrick Lydon; Ahmed Magan; Abdelmajid Tibouti; Benjamin Johns; Raymond Hutubessy; Peter Salama; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2008-01       Impact factor: 9.408

4.  Thermostability of Measles and Rubella Vaccines in a Microneedle Patch.

Authors:  Jessica C Joyce; Marcus L Collins; Paul A Rota; Mark R Prausnitz
Journal:  Adv Ther (Weinh)       Date:  2021-07-28

5.  Physical accessibility and utilization of health services in Yemen.

Authors:  Abdullah Al-Taiar; Allan Clark; Joseph C Longenecker; Christopher J M Whitty
Journal:  Int J Health Geogr       Date:  2010-07-21       Impact factor: 3.918

6.  The impact of supplementary immunization activities on the epidemiology of measles in Tianjin, China.

Authors:  Abram L Wagner; Ying Zhang; Bhramar Mukherjee; Yaxing Ding; Eden V Wells; Matthew L Boulton
Journal:  Int J Infect Dis       Date:  2016-03-10       Impact factor: 3.623

7.  Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.

Authors:  Carol E Levin; Hoang Van Minh; John Odaga; Swampa Sarit Rout; Diep Nguyen Thi Ngoc; Lysander Menezes; Maria Ana Mendoza Araujo; D Scott LaMontagne
Journal:  Bull World Health Organ       Date:  2013-06-19       Impact factor: 9.408

8.  It's a long, long walk: accessibility to hospitals, maternity and integrated health centers in Niger.

Authors:  Justine I Blanford; Supriya Kumar; Wei Luo; Alan M MacEachren
Journal:  Int J Health Geogr       Date:  2012-06-27       Impact factor: 3.918

9.  Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.

Authors:  Stéphane Verguet; Waasila Jassat; Melanie Y Bertram; Stephen M Tollman; Christopher J L Murray; Dean T Jamison; Karen J Hofman
Journal:  Glob Health Action       Date:  2013-03-01       Impact factor: 2.640

10.  Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali.

Authors:  Zana C Somda; Martin I Meltzer; Helen N Perry; Nancy E Messonnier; Usman Abdulmumini; Goitom Mebrahtu; Massambou Sacko; Kandioura Touré; Salimata Ouédraogo Ki; Tuoyo Okorosobo; Wondimagegnehu Alemu; Idrissa Sow
Journal:  Cost Eff Resour Alloc       Date:  2009-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.